Serum protein profiling reveals baseline and pharmacodynamic biomarker signatures associated with clinical outcome in mCRC patients treated with chemotherapy ± cediranib.
Br J Cancer
; 111(8): 1590-604, 2014 Oct 14.
Article
in En
| MEDLINE
| ID: mdl-25121956
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quinazolines
/
Blood Proteins
/
Colorectal Neoplasms
/
Biomarkers, Tumor
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Br J Cancer
Year:
2014
Type:
Article
Affiliation country:
United kingdom